Commitment COM-171
Post-approval commitment for TFDA-2024-0071. Category: REMS. Priority: medium.
Commitment ID
COM-171
Application
Authority
Taiwan Food and Drug Administration
Category
REMS
Priority
medium
Status
Blocked
Due Date
2025-06-20
Completed At
—
Owner
Tomoko Ikeda
Created
2023-03-22
Description
Complete Phase IV post-marketing observational study (n=500)
Evidence (0)
No evidence documents attached. Upload evidence to mark this commitment as complete.